Patent 9573952 was granted and assigned to Gilead Sciences on February, 2017 by the United States Patent and Trademark Office.
The present invention provides methods of preparing 4-amino-2-butoxy-8-(3-(pyrrolidin-1-ylmethyl)benzyl)-7,8-dihydropteridin-6(5H)-one and related compounds.